Characteristics of circulating tumor cells in newly diagnosed metastatic pancreatic adenocarcinoma.

被引:0
|
作者
Starr, Jason Scott [1 ]
Parekh, Hiral D. [1 ]
Varillas, Jose I. [1 ]
Ivey, Alison Marguerite [1 ]
Barnes, Isis [1 ]
McEwan, Margaret A. [1 ]
Allegra, Carmen Joseph [1 ]
Trevino, Jose Gilberto [1 ]
Cioffi, Jessica [1 ]
Hughes, Steven J. [1 ]
Mramba, Lazarus [1 ]
Zhang, Jinling [1 ]
Fan, Z. Hugh [1 ]
George, Thomas J. [1 ]
机构
[1] Univ Florida, Gainesville, FL USA
关键词
D O I
10.1200/JCO.2018.36.4_suppl.304
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
304
引用
收藏
页数:1
相关论文
共 50 条
  • [1] Circulating tumor cells as a surrogate for treatment response in patients with metastatic pancreatic adenocarcinoma.
    Parekh, Hiral D.
    Starr, Jason Scott
    Varillas, Jose I.
    Ivey, Alison Marguerite
    Barnes, Isis
    McEwan, Margaret A.
    Trevino, Jose Gilberto
    Cioffi, Jessica
    Hughes, Steven J.
    Grajo, Joseph
    Fan, Z. Hugh
    Allegra, Carmen Joseph
    George, Thomas J.
    JOURNAL OF CLINICAL ONCOLOGY, 2018, 36 (04)
  • [2] Harnessing the heterogeneity of circulating hybrid cells in pancreatic adenocarcinoma.
    Walker, Brett Scott
    Sengupta, Sidharth
    Parappilly, Michael
    Ors, Aysegul
    Fischer, Jared
    Sutton, Thomas
    Sheppard, Brett
    Mayo, Skye
    Wong, Melissa
    CANCER RESEARCH, 2020, 80 (21)
  • [4] Circulating tumor cells: A novel prognostic factor for newly diagnosed metastatic breast cancer
    Cristofanilli, M
    Hayes, DF
    Budd, GT
    Ellis, MJ
    Stopeck, A
    Reuben, JM
    Doyle, GV
    Matera, J
    Allard, WJ
    Miller, MC
    Fritsche, HA
    Hortobagyi, GN
    Terstappen, LWMM
    JOURNAL OF CLINICAL ONCOLOGY, 2005, 23 (07) : 1420 - 1430
  • [5] Targeting tumor infiltrating myeloid cells to inhibit tumor progression in pancreatic adenocarcinoma.
    Nywening, Timothy M.
    Belt, Brian
    Cusworth, Brian M.
    Panni, Roheena Z.
    Sanford, Dominic E.
    Hawkins, William G.
    DeNardo, David G.
    Gillanders, William E.
    Goedegebuure, Peter S.
    Linehan, David
    JOURNAL OF CLINICAL ONCOLOGY, 2015, 33 (15)
  • [6] Prognostic implication of circulating tumor-derived KRAS mutation in pancreatic ductal adenocarcinoma.
    Kim, Min Kyeong
    Lee, Dong-Eun
    Kim, Yun Hee
    Park, Sang Jae
    Woo, Sang Myung
    Kong, Sun-Young
    CANCER RESEARCH, 2021, 81 (13)
  • [7] Circulating Tumor Cells as a Biomarker in Pancreatic Ductal Adenocarcinoma
    Liu, Han
    Sun, Bo
    Wang, Shengnan
    Liu, Congjin
    Lu, Yun
    Li, Ding
    Liu, Xingdang
    CELLULAR PHYSIOLOGY AND BIOCHEMISTRY, 2017, 42 (01) : 373 - 382
  • [8] Prognostic Significance of MUC-1 in Circulating Tumor Cells in Patients With Metastatic Pancreatic Adenocarcinoma
    Dotan, Efrat
    Alpaugh, R. Katherine
    Ruth, Karen
    Negin, Benjamin P.
    Denlinger, Crystal S.
    Hall, Michael J.
    Astsaturov, Igor
    McAleer, Cecilia
    Fittipaldi, Patricia
    Thrash-Bingham, Catherine
    Meropol, Neal J.
    Cohen, Steven J.
    PANCREAS, 2016, 45 (08) : 1131 - 1135
  • [9] Importance of circulating tumor cells in newly diagnosed colorectal cancer
    Van Dalum, Guus
    Stam, Gerrit-Jan
    Scholten, Loes F. A.
    Mastboom, Walter J. B.
    Vermes, Istvan
    Tibbe, Arjan G. J.
    De Groot, Marco R.
    Terstappen, Leon W. M. M.
    INTERNATIONAL JOURNAL OF ONCOLOGY, 2015, 46 (03) : 1361 - 1368
  • [10] Importance of circulating tumor cells in newly diagnosed colorectal cancer
    van Dalum, Guus
    de Groot, Marco R.
    Stam, Gerrit-Jan
    Scholten, Loes F. A.
    Mastboom, Walter J. B.
    Vermes, Istvan
    Tibbe, Arjan G. J.
    Terstappen, Leon W. M. M.
    CANCER RESEARCH, 2014, 74 (19)